HH

H&Q Healthcare Investors

North America, Massachusetts, United States, Boston

Description

H&Q Healthcare Investors provides early and later stage funding and is a Massachusetts-based healthcare fund.

Investor Profile

H&Q Healthcare Investors has made 11 investments, with 0 in the past 12 months and 9% as lead.

Stage Focus

  • Series Unknown (27%)
  • Series E (18%)
  • Series D (18%)
  • Post Ipo Equity (9%)
  • Series F (9%)
  • Debt Financing (9%)
  • Series A (9%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Clinical Trials
  • Therapeutics
  • Medical
  • Data Integration
  • Web Browsers
  • Pharmaceutical
  • Medical Device
  • Neuroscience
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does H&Q Healthcare Investors frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 3
Adage Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
Tekla Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 4
Sahsen Ventures
North America, Washington, United States, Seattle
Co-Investments: 1
State of Wisconsin Investment Board
North America, Wisconsin, United States, Madison
Co-Investments: 2
GBS Ventures
Oceania, Victoria, Australia, Melbourne
Co-Investments: 3
Jennison Associates
North America, New York, United States, New York
Co-Investments: 1
MC
North America, New Jersey, United States, Woodcliff Lake
Co-Investments: 2
Bain Capital Public Equity
North America, Massachusetts, United States, Boston
Co-Investments: 1

Which angels does H&Q Healthcare Investors often collaborate with?

TJ
North America, Massachusetts, United States, Cambridge
Shared Deals: 2
Shared Deals: 1

What are some of recent deals done by H&Q Healthcare Investors?

Neurovance

Cambridge, Massachusetts, United States

Neurovance is a clinical-stage neuroscience company that discovered and developed centanafadine (CTN) to help adults and children with ADHD.

BiotechnologyClinical TrialsHealth CareNeuroscience
Series AApr 3, 2014
Amount Raised: $6,300,000
CardioKinetix

Menlo Park, California, United States

CardioKinetix is a medical device company offering the Parachutem, a catheter-based treatment for heart failure.

BiotechnologyHealth CareMedical Device
Series EMar 1, 2013
Amount Raised: $23,000,000
Labcyte

San Jose, California, United States

Lab­cyte is the maker of Echo Acoustic Liquid Handling systems for life sciences.

Alternative MedicineBiotechnologyLife SciencePharmaceutical
Series DJan 8, 2013
Amount Raised: $5,300,000
Neurovance

Cambridge, Massachusetts, United States

Neurovance is a clinical-stage neuroscience company that discovered and developed centanafadine (CTN) to help adults and children with ADHD.

BiotechnologyClinical TrialsHealth CareNeuroscience
Series UnknownOct 18, 2012
Amount Raised: $7,000,000
Celladon

La Jolla, California, United States

Celladon is a biotechnology company developing molecular therapies for the treatment of heart failure.

BiotechnologyHealth CareHospitalTherapeutics
Series UnknownFeb 15, 2012
Amount Raised: $43,000,000
Puma Biotechnology

Los Angeles, California, United States

Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.

BiotechnologyMedicalTherapeutics
Post Ipo EquityOct 5, 2011
Amount Raised: $55,000,000
PHT Corporation

Boston, Massachusetts, United States

PHT Clinical Networks, a provider of Web-based clinical trial direct data capture and management technologies

Clinical TrialsData IntegrationWeb Browsers
Series FAug 4, 2008
Amount Raised: $1,032,000
CardioNet

Conshohocken, Pennsylvania, United States

CardioNet provides real-time ambulatory outpatient management solutions to monitor clinical information of people.

BiotechnologyHealth CareMedical Device
Series DMar 1, 2004
Amount Raised: $10,000,000
PHT Corporation

Boston, Massachusetts, United States

PHT Clinical Networks, a provider of Web-based clinical trial direct data capture and management technologies

Clinical TrialsData IntegrationWeb Browsers
Series EOct 2, 2003
Amount Raised: $4,959,000
Therion Biologics

Cambridge, Massachusetts, United States

Therion Biologics Corporation develops therapeutic vaccines for cancer patients.

BiotechnologyHealth CareMedicalTherapeutics
Series UnknownOct 30, 2001
Amount Raised: $36,500,000